These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 15364412)
21. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition. Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920 [TBL] [Abstract][Full Text] [Related]
22. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104 [TBL] [Abstract][Full Text] [Related]
23. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity. Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400 [TBL] [Abstract][Full Text] [Related]
24. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1. Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464 [TBL] [Abstract][Full Text] [Related]
25. Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid. Craft JM; Watterson DM; Marks A; Van Eldik LJ Glia; 2005 Aug; 51(3):209-16. PubMed ID: 15810011 [TBL] [Abstract][Full Text] [Related]
26. Alzheimer's theory makes a splash. Schnabel J Nature; 2009 May; 459(7245):310. PubMed ID: 19458681 [No Abstract] [Full Text] [Related]
27. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Carro E; Trejo JL; Gerber A; Loetscher H; Torrado J; Metzger F; Torres-Aleman I Neurobiol Aging; 2006 Sep; 27(9):1250-7. PubMed ID: 16183170 [TBL] [Abstract][Full Text] [Related]
29. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521 [TBL] [Abstract][Full Text] [Related]
30. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. Zhang G; Kernan KA; Collins SJ; Cai X; López-Guisa JM; Degen JL; Shvil Y; Eddy AA J Am Soc Nephrol; 2007 Mar; 18(3):846-59. PubMed ID: 17267741 [TBL] [Abstract][Full Text] [Related]
31. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease? Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173 [TBL] [Abstract][Full Text] [Related]
32. Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. Eckman EA; Adams SK; Troendle FJ; Stodola BA; Kahn MA; Fauq AH; Xiao HD; Bernstein KE; Eckman CB J Biol Chem; 2006 Oct; 281(41):30471-8. PubMed ID: 16912050 [TBL] [Abstract][Full Text] [Related]